• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Mylan has drawn bipartisan anger for raising the price of the EpiPen by 400 percent since acquiring it in 2007. The price tag now runs $600 for a two-pack of the life-saving drug. (AP Photo/Pablo Martinez Monsivais)
    Healthcare

    EpiPen maker racking up taxpayer dollars

    Robert King -
    October 6, 2016 6:30 pm
    0
    Two-thirds or more of respondents in a new poll favor policies to bring down prescription prices. (AP Photo/Rich Pedroncelli)
    Healthcare

    Americans favor policies to lower drug prices

    Paige Winfield Cunningham -
    September 29, 2016 7:00 am
    0
    Lawmakers want to know if Mylan defrauded Medicaid by classifying the EpiPen as a generic drug. (George Frey/Bloomberg)
    Healthcare

    Senators ask Justice Department to investigate EpiPen maker

    Robert King -
    September 28, 2016 4:47 pm
    0
    Premiums for Medicare's prescription drug plans are expected to rise by about 4 percent next year, a new analysis found. (AP Photo/Rich Pedroncelli,file)
    Healthcare

    Seniors to pay more for Medicare Part D next year

    Robert King -
    September 28, 2016 4:05 pm
    0
    Healthcare

    Cummings: Action on high drug prices appears unlikely

    Robert King -
    September 22, 2016 4:36 pm
    0
    Healthcare

    Cummings: EpiPen CEO raised prices to get ‘filthy rich’

    Robert King -
    September 21, 2016 7:40 pm
    0
    Mylan acquired the patent for EpiPen in 2007, becoming the sole seller and marketer of this life-saving medication. (Daniel Acker/Bloomberg)
    Healthcare

    Washington’s monopoly policy

    Deane Waldman -
    September 15, 2016 1:23 pm
    0
    Martin Shkreli tweeted his demand on the same day the House Oversight and Government Reform Committee announced a Sept. 21 hearing to scrutinize the price increase of allergy treatment EpiPens. (AP Photo)
    Healthcare

    Pharma’s Shkreli wants immunity to testify to Congress

    Robert King -
    September 14, 2016 7:19 pm
    0
    GAO finds that 300 generic drugs had at least one price hike of 100 percent or more since 2010. (AP Photo/Matt Rourke)
    Healthcare

    Senators lament spikes in generic drugs

    Robert King -
    September 14, 2016 6:43 pm
    0
    Agency has approved three competitors, but doesn't regulate prices, official says. (AP Photo/Jose Luis Magana)
    Healthcare

    FDA defends itself from EpiPen critics

    Robert King -
    September 14, 2016 4:53 pm
    0
    1...116117118...156Page 117 of 156
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.